Develops non-invasive pharmaceutical nasal sprays to restore natural airway reflexes and treat obstructive sleep apnea.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Mosanna Therapeutics is developing an easy-to-use nighttime nasal spray as a pharmaceutical solution to treat obstructive sleep apnea by restoring the body’s natural airway control. Their innovative therapy aims to minimize reliance on uncomfortable mechanical devices by reactivating upper airway muscles during sleep.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Mosanna Therapeutics Management Team
Investors
Forbion Capital Partners
Norwest Venture Partners
Mosanna Therapeutics Valuations & Financials
View real-time NPM data on Mosanna Therapeutics stock including daily Mosanna Therapeutics stock price estimates, valuation history, and historical share price information. Access Mosanna Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Mosanna Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Mosanna Therapeutics? Get in touch to learn more.
Similar Companies
like Mosanna Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Matic
FinTech
Embedding effortless insurance quoting into loan workflows via pre-filled, multi-carrier coverage options that simplify home and auto protection.
Cybrexa Therapeutics
Develops tumor-targeting peptide-drug conjugates for precise, antigen-independent delivery of potent anti-cancer therapies.
Nanochon
Healthcare & Life Sciences
Delivers a synthetic implant which restores cartilage defects and supports long-term healing through engineered structure and material design.
TurbineOne
Delivers wearable tech and ML tools for frontline personnel to enhance situational awareness in challenging environments.
ACT-ion
Mobility & Transportation
Produces advanced cathode active battery materials using a streamlined, chemistry‑versatile manufacturing process.
Tome
Enables users to quickly create interactive, visually engaging presentations using AI-powered design and storytelling tools online.
Column
Enterprise Software
Software platform streamlines publication of legal notices, obituaries and classifieds for media companies and organizations.
VVDN Technologies
Engineering firm delivers product development, IoT solutions and embedded systems to help businesses enhance technology offerings.
FAQ
We have answers
Mosanna Therapeutics stock does not trade on public stock exchanges. Mosanna Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Mosanna Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Mosanna Therapeutics Stock does not trade on public stock exchanges. In order to sell Mosanna Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Mosanna Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Mosanna Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Mosanna Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Mosanna Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Mosanna Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Mosanna Therapeutics is a private company and has not had an IPO. There is currently no Mosanna Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Mosanna Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
